Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
11.32
-0.04 (-0.35%)
At close: Jun 27, 2025, 4:00 PM
11.38
+0.06 (0.53%)
After-hours: Jun 27, 2025, 5:59 PM EDT
Sotera Health Company Stock Forecast
Stock Price Forecast
The 5 analysts that cover Sotera Health Company stock have a consensus rating of "Strong Buy" and an average price target of $16, which forecasts a 41.34% increase in the stock price over the next year. The lowest target is $13 and the highest is $20.
Price Target: $16 (+41.34%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Sotera Health Company stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 5 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $15 → $13 | Buy | Maintains | $15 → $13 | +14.84% | Jun 24, 2025 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $14 → $17 | Hold → Strong Buy | Upgrades | $14 → $17 | +50.18% | May 5, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $15 → $13 | Hold | Maintains | $15 → $13 | +14.84% | Apr 23, 2025 |
| Barclays | Barclays | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | +6.01% | Apr 10, 2025 |
| Barclays | Barclays | Buy Maintains $17 → $16 | Buy | Maintains | $17 → $16 | +41.34% | Feb 28, 2025 |
Financial Forecast
Revenue This Year
1.15B
from 1.10B
Increased by 4.78%
Revenue Next Year
1.22B
from 1.15B
Increased by 5.90%
EPS This Year
0.76
from 0.16
Increased by 381.83%
EPS Next Year
0.86
from 0.76
Increased by 13.79%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.2B | 1.3B | 1.4B | |
| Avg | 1.2B | 1.2B | 1.3B | |
| Low | 1.1B | 1.2B | 1.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 9.9% | 11.5% | 11.8% | |
| Avg | 4.8% | 5.9% | 6.4% | |
| Low | 0.9% | 1.8% | 1.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.82 | 0.93 | 1.04 | |
| Avg | 0.76 | 0.86 | 0.96 | |
| Low | 0.72 | 0.80 | 0.91 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 422.3% | 23.3% | 20.9% | |
| Avg | 381.8% | 13.8% | 11.2% | |
| Low | 361.9% | 6.4% | 6.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.